Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
about
Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension.Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy.Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.Long Noncoding RNA LOC441178 Reduces the Invasion and Migration of Squamous Carcinoma Cells by Targeting ROCK1
P2860
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
@en
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
@nl
type
label
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
@en
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
@nl
prefLabel
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
@en
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
@nl
P2093
P2860
P1476
Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
@en
P2093
Alessandra B Pernis
Cristina Rozo
Jane E Salmon
Kyriakos A Kirou
Reena Khianey Maharaj
Sanjay Gupta
Susan M Goodman
Vivian P Bykerk
P2860
P304
P356
10.1136/ANNRHEUMDIS-2016-209850
P407
P577
2016-11-09T00:00:00Z